Butylboronicacid

CAS No. 4426-47-5

Butylboronicacid( —— )

Catalog No. M36861 CAS No. 4426-47-5

Butylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Butylboronicacid
  • Note
    Research use only, not for human use.
  • Brief Description
    Butylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.
  • Description
    Butylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4426-47-5
  • Formula Weight
    101.94
  • Molecular Formula
    C4H11BO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCB(O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Apigenin-6-C-β-D-xyl...

    Apigenin-6-C-β-D-xylopyranosyl-8-C-α-L-arabinopyranoside is a flavonoid with antioxidant activity. Apigenin-6-C-β-D-xylopyranosyl-8-C-α-L-arabinopyranoside can be isolated from Traditional Chinese Medicine TiepiShihu.

  • Methyl jasmonate

    Methyl jasmonate is a phytohormone involved in plant defenses under stress conditions. Methyl jasmonate can improve antioxidant properties of blueberry leaf extracts (mainly anthocyanins), and decrease the viability and migration capacity of AGS cells. Anticarcinogenic activity.

  • BDA 366

    BDA-366 specifically targets the BH4 domain of Bcl2 BDA-366 and suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change.